Allegro Ophthalmics LLC, based in San Juan Capistrano, CA, is a pioneering company that is revolutionizing the treatment of ocular diseases through integrin-regulating therapy. With a focus on ocular diseases with unmet needs such as intermediate dry AMD and dry eye disease, Allegro is dedicated to uncovering groundbreaking treatments for patients who have limited or no options, or who inadequately respond to existing therapies.
Driven by a science-based approach, Allegro is committed to improving mitochondrial dysfunction and downregulating oxidative stress response to create homeostatic harmony in the eyes. By disrupting integrin functions, their innovative mechanism of action aims to redefine the treatment of ocular diseases, setting the pace in ocular care.
Generated from the website